FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Molekulare Mechanismen der Organfibrose
Reallocation / Closing: 30.09.2022
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 3 – Rheumatology and Immunology
Lehrstuhl für Innere Medizin III
Overview
Publications
(344)
Research Grants
(1)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
The novel molecular mechanism of pulmonary fibrosis: insight into lipid metabolism from reanalysis of single-cell RNA-seq databases (2024)
Shi X, Chen Y, Shi M, Gao F, Huang L, Wang W, Wei D, et al.
Journal article, Review article
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis (Arthritis Research & Therapy, (2015), 17, 1, (145), 10.1186/s13075-015-0659-5) (2023)
Ruzehaji N, Avouac J, Elhai M, Frechet M, Frantz C, Ruiz B, Distler J, Allanore Y
Journal article, Erratum
Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey (2023)
Weiß M, Holzer MT, Muehlensiepen F, Ignatyev Y, Fiehn C, Bauhammer J, Schmidt J, et al.
Journal article
Correction to: Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin (Biomedicines, (2021), 9, 6, (650), 10.3390/biomedicines9060650) (2023)
Štorkánová H, Štorkánová L, Navrátilová A, Bečvář V, Hulejová H, Oreská S, Heřmánková B, et al.
Journal article, Erratum
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients with Systemic Sclerosis Sine Scleroderma: Data from the International EUSTAR Database (2023)
Lescoat A, Huang S, Carreira PE, Siegert E, De Vries-Bouwstra J, Distler J, Smith V, et al.
Journal article
Rapid single-cell physical phenotyping of mechanically dissociated tissue biopsies (2023)
Soteriou D, Kubankova M, Schweitzer C, Lopez Posadas R, Pradhan R, Thoma OM, Györfi AH, et al.
Journal article
Activation of the alpha7 nicotinic acetylcholine receptor ameliorates skin fibrosis and reduces TGF-beta1-induced collagen synthesis in human dermal fibroblasts by modulating JunB (2023)
Stegemann A, Dreissigacker K, Summa L, Flis D, Distler J, Ziolkowski W, Steinbrink K, Boehm M
Conference contribution
Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. (2023)
Bergmann C, Müller F, Distler J, Györfi AH, Völkl S, Aigner M, Kretschmann S, et al.
Journal article, Letter
The Exciting Future for Scleroderma: What Therapeutic Pathways Are on the Horizon? (2023)
Distler J, Riemekasten G, Denton CP
Journal article, Review article
Assessment of myocardial fibrosis in patients with systemic sclerosis using [Ga-68]Ga-FAPI-04-PET-CT (2022)
Treutlein C, Distler J, Tascilar K, Chenguiti Fakhouri S, Györfi AH, Atzinger A, Matei AE, et al.
Journal article
‹
1
2
3
...
35
›